Logo image of LUXH

LUXURBAN HOTELS INC (LUXH) Stock Fundamental Analysis

NASDAQ:LUXH - Nasdaq - US21985R3030 - Common Stock - Currency: USD

0.32  -0.37 (-53.5%)

After market: 0.317 0 (-0.94%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LUXH. LUXH was compared to 64 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of LUXH have multiple concerns. LUXH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LUXH had positive earnings in the past year.
In the past year LUXH has reported a negative cash flow from operations.
LUXH had negative earnings in each of the past 5 years.
LUXH had negative operating cash flow in 4 of the past 5 years.
LUXH Yearly Net Income VS EBIT VS OCF VS FCFLUXH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of LUXH (-74.66%) is worse than 91.80% of its industry peers.
Industry RankSector Rank
ROA -74.66%
ROE N/A
ROIC N/A
ROA(3y)-31.72%
ROA(5y)-235.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LUXH Yearly ROA, ROE, ROICLUXH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 1K 2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LUXH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LUXH Yearly Profit, Operating, Gross MarginsLUXH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

LUXH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LUXH has been reduced compared to 1 year ago.
Compared to 1 year ago, LUXH has an improved debt to assets ratio.
LUXH Yearly Shares OutstandingLUXH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
LUXH Yearly Total Debt VS Total AssetsLUXH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -3.31, we must say that LUXH is in the distress zone and has some risk of bankruptcy.
LUXH has a worse Altman-Z score (-3.31) than 88.52% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.31
ROIC/WACCN/A
WACC47.34%
LUXH Yearly LT Debt VS Equity VS FCFLUXH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 -5M -10M -15M

2.3 Liquidity

LUXH has a Current Ratio of 0.03. This is a bad value and indicates that LUXH is not financially healthy enough and could expect problems in meeting its short term obligations.
LUXH's Current ratio of 0.03 is on the low side compared to the rest of the industry. LUXH is outperformed by 96.72% of its industry peers.
LUXH has a Quick Ratio of 0.03. This is a bad value and indicates that LUXH is not financially healthy enough and could expect problems in meeting its short term obligations.
LUXH's Quick ratio of 0.03 is on the low side compared to the rest of the industry. LUXH is outperformed by 96.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
LUXH Yearly Current Assets VS Current LiabilitesLUXH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for LUXH have decreased strongly by -16327.37% in the last year.
Looking at the last year, LUXH shows a very negative growth in Revenue. The Revenue has decreased by -19.87% in the last year.
The Revenue has been growing by 103.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-16327.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15123.51%
Revenue 1Y (TTM)-19.87%
Revenue growth 3Y103.08%
Revenue growth 5YN/A
Sales Q2Q%-57.92%

3.2 Future

The Earnings Per Share is expected to grow by 31.90% on average over the next years. This is a very strong growth
LUXH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 44.67% yearly.
EPS Next Y-217.94%
EPS Next 2Y-20.16%
EPS Next 3Y31.9%
EPS Next 5YN/A
Revenue Next Year-5.75%
Revenue Next 2Y4.34%
Revenue Next 3Y46.34%
Revenue Next 5Y44.67%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LUXH Yearly Revenue VS EstimatesLUXH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
LUXH Yearly EPS VS EstimatesLUXH Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20 25

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 1.00, which indicates a rather cheap valuation of LUXH.
98.36% of the companies in the same industry are more expensive than LUXH, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 29.63, LUXH is valued rather cheaply.
LUXH is valuated cheaply with a Price/Forward Earnings ratio of 1.57.
Based on the Price/Forward Earnings ratio, LUXH is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
LUXH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 1
Fwd PE 1.57
LUXH Price Earnings VS Forward Price EarningsLUXH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LUXH Per share dataLUXH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

LUXH's earnings are expected to grow with 31.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.16%
EPS Next 3Y31.9%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LUXH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUXURBAN HOTELS INC

NASDAQ:LUXH (1/16/2025, 8:00:01 PM)

After market: 0.317 0 (-0.94%)

0.32

-0.37 (-53.5%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-11 2024-11-11/amc
Earnings (Next)N/A N/A
Inst Owners12.59%
Inst Owner ChangeN/A
Ins Owners7.23%
Ins Owner Change41.07%
Market Cap723.20K
Analysts43.33
Price TargetN/A
Short Float %3.78%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-0.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-43.22%
Min Revenue beat(2)-54.1%
Max Revenue beat(2)-32.34%
Revenue beat(4)1
Avg Revenue beat(4)-26.12%
Min Revenue beat(4)-54.1%
Max Revenue beat(4)3.09%
Revenue beat(8)3
Avg Revenue beat(8)-19.78%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1
Fwd PE 1.57
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.32
EY100%
EPS(NY)0.2
Fwd EY63.75%
FCF(TTM)-21.19
FCFYN/A
OCF(TTM)-21.22
OCFYN/A
SpS32.21
BVpS-33.6
TBVpS-33.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -74.66%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.72%
ROA(5y)-235.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -3.31
F-Score2
WACC47.34%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.4%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16327.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15123.51%
EPS Next Y-217.94%
EPS Next 2Y-20.16%
EPS Next 3Y31.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.87%
Revenue growth 3Y103.08%
Revenue growth 5YN/A
Sales Q2Q%-57.92%
Revenue Next Year-5.75%
Revenue Next 2Y4.34%
Revenue Next 3Y46.34%
Revenue Next 5Y44.67%
EBIT growth 1Y-20552.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-7.8%
EBIT Next 3Y68.28%
EBIT Next 5Y60.38%
FCF growth 1Y-211.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-213.46%
OCF growth 3YN/A
OCF growth 5YN/A